 |
|
Become an MS Research Champion How We Will Restore Function (.pdf) |
Just a few short years ago, there was little belief that nervous system repair was even possible. Through the Society’s tireless efforts and multi-million dollar funding, there is not just belief, but a whole new field that has emerged to pursue strategies to repair the nervous system and restore function to people with MS.
Potential cell therapies are now in clinical trials, and creative new rehabilitation strategies and symptom management techniques are being explored to maximize abilities and to treat troubling symptoms.
But more must be done to give back what has been lost. Here’s how:
- We must better understand how nerves and myelin work normally, and stimulate repair
- We must aggressively pursue clinical trials of new cell therapies and other therapeutic approaches to rebuild the nervous system
- We must ensure that innovative rehabilitation techniques are developed to maximize function, and develop better ways to reduce MS symptoms, including psychosocial symptoms
- We must provide data on optimal health care delivery and policy to fuel advocacy efforts to improve quality of care and quality of life
Research News Related to Restoring Function
Studies Report Progress Understanding What Drives Repair of the Brain’s Insulating Myelin, Which is Damaged by MS
May 08, 2013
Researchers at the universities of Edinburgh and Cambridge, and at Stanford, have reported separate studies making inroads to understanding factors that stimulate the repair of myelin, the nerve insulation that is a target of multiple sclerosis. These important laboratory discoveries, supported in part by the National MS Society, are still in early stages and need to be confirmed and expanded, but they could eventually lead to promising new therapeutic approaches to stimulating myelin repair to restore function in people with MS.
Meeting of MS Outcome Assessments Consortium and FDA Clears Pathway for New Tool for Clinical Trials in MS, Particularly Progressive Forms
Apr 18, 2013
The National MS Society-funded MS Outcome Assessments Consortium (MSOAC) held its first annual meeting with the U.S. Food and Drug Administration on April 1-2 to discuss steps needed to “qualify” a new measure of MS disability that will be recognized by the FDA and the European Medicines Agency to speed new therapies for MS, particularly progressive forms of the disease.
$18 Million in New Research Projects Launched To Stop MS, Restore Function and End It Forever - Part of 2013 investment of over $47 million in cutting-edge research projects
Apr 18, 2013
The National Multiple Sclerosis Society has committed another $18 million to support up to 65 new MS research projects. These new awards are part of a comprehensive research strategy aimed at stopping MS, restoring function that has been lost, and ending the disease forever.
more news